Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer.

MLA

Loupakis, Fotios, et al. “Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer.” New England Journal of Medicine, vol. 371, no. 17, Oct. 2014, pp. 1609–18. EBSCOhost, https://doi.org/10.1056/NEJMoa1403108.

APA

Loupakis, F., Cremolini, C., Masi, G., Lonardi, S., Zagonel, V., Salvatore, L., Cortesi, E., Tomasello, G., Ronzoni, M., Spadi, R., Zaniboni, A., Tonini, G., Buonadonna, A., Amoroso, D., Chiara, S., Carlomagno, C., Boni, C., Allegrini, G., Boni, L., & Falcone, A. (2014). Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer. New England Journal of Medicine, 371(17), 1609–1618. https://doi.org/10.1056/NEJMoa1403108

Chicago

Loupakis, Fotios, Chiara Cremolini, Gianluca Masi, Sara Lonardi, Vittorina Zagonel, Lisa Salvatore, Enrico Cortesi, et al. 2014. “Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer.” New England Journal of Medicine 371 (17): 1609–18. doi:10.1056/NEJMoa1403108.